Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
A Phase 1 Dose-Escalation, Food Effect, and Drug-Drug Interaction Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MALT1 Inhibitor, SGR-1505, in Healthy Volunteers.
Journal: Clinical pharmacology in drug development
Published: September 18, 2025
Anti-CD38 monoclonal antibody interference with blood compatibility testing: Differentiating isatuximab and daratumumab via functional epitope mapping.
Journal: Transfusion
Published: August 20, 2021
Effect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of a Single Dose of Oral Ivosidenib in Otherwise Healthy Participants.
Journal: Clinical pharmacology in drug development
Published: January 10, 2020
Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma.
Journal: American journal of hematology
Published: August 21, 2019
A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant-ineligible multiple myeloma.
Journal: British journal of haematology
Published: November 30, 2017
Solitary plasmacytoma of the uvula.
Journal: American journal of hematology
Published: January 13, 2014
Docetaxel/Cyclophosphamide-induced ultraviolet recall dermatitis.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 26, 2011
Showing 1-7 of 7
Last Updated: 09/26/2026